1 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Sham Sunder Kakar: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combination Therapy for Recurrent Ovarian Cancer DOXIL, Withaferin A, Ashwagandha - Recurrent Ovarian Cancer | Phase 1 / Phase 2 | Recruiting | Sham Sunder Kakar | 72 | 2024-09-25 | 2026-03-19 |
Ashwagandha (1) · liposomal doxorubicin (1) · withaferin A (1)
United States (1)